Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Andrews

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Communicable Diseases Intelligence (2018)|August 18, 2022
Outbreak of SARS-CoV-2 Delta variant on a single liquified natural gas (LNG) vessel, with estimates of vaccine effectivenessNicolas Smoll, Jacina Walker, Mahmudul Hassan Al Imam, et al.
Communicable Diseases Intelligence Quarterly Report|August 27, 2002
Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000Peter McIntyre, Heather Gidding, Robin Gilmour, et al.
The Pediatric Infectious Disease Journal|September 27, 2014
Predictors of disease severity in children hospitalized for pertussis during an epidemicHelen Marshall, Michelle Clarke, Kavita Rasiah, et al.
BMC Public Health|December 1, 2023
Having a real say: findings from first nations community panels on pandemic influenza vaccine distributionKristy Crooks, Kylie Taylor, Kiara Burns, et al.
International Journal of Pediatric Otorhinolaryngology|June 5, 2016
General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccinesAmanda J Leach, Christine Wigger, Jemima Beissbarth, et al.
BMC Pediatrics|October 21, 2015
Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccineAmanda Jane Leach, Christine Wigger, Kim Hare, et al.
Acta Tropica|July 23, 2014
Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIEKate Mounsey, Therese Kearns, Melanie Rampton, et al.
Clinical & Translational Immunology|November 9, 2017
Repeat pneumococcal polysaccharide vaccination does not impair functional immune responses among Indigenous AustraliansPaul V Licciardi, Edwin Hoe, Zheng Quan Toh, et al.
The New England Journal of Medicine|December 10, 2015
Mass Drug Administration for Scabies Control in a Population with Endemic DiseaseLucia Romani, Margot J Whitfeld, Josefa Koroivueta, et al.
Communicable Diseases Intelligence (2018)|April 26, 2022
Defining the peak: Point prevalence of SARS-CoV-2 using randomised samplingAndre L Wattiaux, Fiona May, Terresa Allen, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Communicable Diseases Intelligence (2018)|August 18, 2022
Outbreak of SARS-CoV-2 Delta variant on a single liquified natural gas (LNG) vessel, with estimates of vaccine effectivenessNicolas Smoll, Jacina Walker, Mahmudul Hassan Al Imam, et al.
Communicable Diseases Intelligence Quarterly Report|August 27, 2002
Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000Peter McIntyre, Heather Gidding, Robin Gilmour, et al.
The Pediatric Infectious Disease Journal|September 27, 2014
Predictors of disease severity in children hospitalized for pertussis during an epidemicHelen Marshall, Michelle Clarke, Kavita Rasiah, et al.
BMC Public Health|December 1, 2023
Having a real say: findings from first nations community panels on pandemic influenza vaccine distributionKristy Crooks, Kylie Taylor, Kiara Burns, et al.
International Journal of Pediatric Otorhinolaryngology|June 5, 2016
General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccinesAmanda J Leach, Christine Wigger, Jemima Beissbarth, et al.
BMC Pediatrics|October 21, 2015
Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccineAmanda Jane Leach, Christine Wigger, Kim Hare, et al.
Acta Tropica|July 23, 2014
Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIEKate Mounsey, Therese Kearns, Melanie Rampton, et al.
Clinical & Translational Immunology|November 9, 2017
Repeat pneumococcal polysaccharide vaccination does not impair functional immune responses among Indigenous AustraliansPaul V Licciardi, Edwin Hoe, Zheng Quan Toh, et al.
The New England Journal of Medicine|December 10, 2015
Mass Drug Administration for Scabies Control in a Population with Endemic DiseaseLucia Romani, Margot J Whitfeld, Josefa Koroivueta, et al.
Communicable Diseases Intelligence (2018)|April 26, 2022
Defining the peak: Point prevalence of SARS-CoV-2 using randomised samplingAndre L Wattiaux, Fiona May, Terresa Allen, et al.
Pageof 6